Kimia utilizes chemotype evolution to create extensive datasets that uncover molecular traits of active and inactive drugs. By automating and applying machine learning to target-specific datasets, the platform accelerates novel compound design, expediting drug discovery.
Founders
Chief Executive Officer
Stig Hansen
Jack Sadowsky
Ray Fucini